CD69 and rheumatoid arthritis: HD and RA-MTX samples showed a relatively balanced distribution, whereas RA patients under JAKi therapy exhibited fewer AIM+ and more AIM− cells, resulting in a lower AIM+/AIM− ratio (Fig. 6A,B).